Gloperba
Payments companies reported to CMS as associated with Gloperba. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gloperba, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gloperba
These are the largest totals companies reported as associated with Gloperba. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Srinivas Nalamachu | Overland Park, KS | Physical Medicine & Rehabilitation | $190,979.54 |
| Angelo Gaffo Llontop | Birmingham, AL | Rheumatology | $2,550.00 |
| Michael Pillinger | New York, NY | Rheumatology | $2,400.00 |
| David Maron | Stanford, CA | Cardiovascular Disease | $2,400.00 |
| Joshua Liu | Morristown, NJ | Rheumatology | $121.92 |
| Cesar Avalos | Morristown, NJ | Rheumatology | $120.03 |
| David Wu | Walnut Creek, CA | Rheumatology | $109.81 |
| Irina Raklyar | Franklin Lakes, NJ | Rheumatology | $87.98 |
| Nilamadhab Mishra | Winston Salem, NC | Rheumatology | $84.55 |
| Zohair Ahmed | Lawrenceville, GA | Rheumatology | $76.88 |
Prescribed Gloperba?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.